DGXQuest Diagnostics
$255.60+47% 1Y
$255.60
$171.9552 weeks$255.60
Latest close: a new 52-week highNov 6, 2026what changed →Oct 29, 2024$135.12 – $255.60 · dashed line: 200-day averageNov 6, 2026
The share price
How DGX is trading
Quest Diagnostics is +47% over the past year while the S&P 500 is +9.2%: 38 points ahead of the market.
+47%
1-year return · S&P 500 +9.2%
- vs 200-day average
- +20%
vs 200-day average · more than 10% above its 200-day average
- RSI (14)
- 77
RSI (14) · at or above 70 on a 0 to 100 scale
- Below its 52-week high
- 0.00%
Below its 52-week high
Details›
- Last close2026-11-06
- $255.60
- 1 monthS&P 500 −4.9%
- +11%
- 1 yearS&P 500 +9.2%
- +47%
- 5 yearsS&P 500 +72%
- +93%
- vs 50-day average$239.34
- +6.8%
- 52-week high
- $255.60
- 52-week low
- $171.95
- Annualised volatility
- 23%
Calendar-year price return
| Year | Return |
|---|---|
| 2017 | +9.2% |
| 2018 | −14% |
| 2019 | +31% |
| 2020 | +14% |
| 2021 | +48% |
| 2022 | −7.8% |
| 2023 | −10% |
| 2024 | +12% |
| 2025 | +17% |
| 2026 YTD | +49% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +1.1% |
| Feb | 10 | 3 of 10 | −0.52% |
| Mar | 10 | 6 of 10 | −0.78% |
| Apr | 10 | 7 of 10 | +6.5% |
| May | 10 | 6 of 10 | +1.6% |
| Jun | 10 | 7 of 10 | +1.7% |
| Jul | 11 | 7 of 11 | +3.0% |
| Aug | 11 | 7 of 11 | +0.31% |
| Sep | 11 | 4 of 11 | −1.7% |
| Oct | 11 | 7 of 11 | +1.3% |
| Nov | 11 | 10 of 11 | +3.6% |
| Dec | 10 | 6 of 10 | −0.02% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
Its returns year by year and month by month, with dividends where it pays them.
Diagnostics & Research
The closest names by size in the same industry